Sarah Cannon Research Center is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Center has participated in 5 clinical trials with 2 currently active.
Therapeutic areas: Advanced Cancer, Pancreatic Cancer, Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma.
Sponsors: Array BioPharma, Kite, A Gilead Company, Angiex, Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Center has 5 clinical trials on record, with 2 currently active. Their work covers Advanced Cancer, Pancreatic Cancer, Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma.
Yes — Sarah Cannon Research Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.